SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 58 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,206,480 | +36.6% | 527,962 | +54.9% | 0.00% | 0.0% |
| Q2 2023 | $8,937,718 | +5.9% | 340,874 | +4.0% | 0.00% | 0.0% |
| Q1 2023 | $8,440,274 | -12.2% | 327,905 | -11.3% | 0.00% | 0.0% |
| Q4 2022 | $9,615,532 | -55.4% | 369,686 | -51.1% | 0.00% | -66.7% |
| Q3 2022 | $21,557,000 | +75.9% | 755,617 | +51.8% | 0.00% | +50.0% |
| Q2 2022 | $12,254,000 | +44.8% | 497,652 | +232.0% | 0.00% | +100.0% |
| Q1 2022 | $8,460,000 | +54.6% | 149,898 | +69.8% | 0.00% | 0.0% |
| Q4 2021 | $5,471,000 | -23.8% | 88,275 | -22.0% | 0.00% | 0.0% |
| Q3 2021 | $7,183,000 | +7.3% | 113,236 | +39.5% | 0.00% | 0.0% |
| Q2 2021 | $6,692,000 | -32.1% | 81,201 | -39.3% | 0.00% | 0.0% |
| Q1 2021 | $9,849,000 | +85.6% | 133,866 | +83.0% | 0.00% | 0.0% |
| Q4 2020 | $5,306,000 | +998.6% | 73,170 | +622.2% | 0.00% | – |
| Q3 2020 | $483,000 | -31.8% | 10,131 | -39.9% | 0.00% | – |
| Q2 2020 | $708,000 | +2341.4% | 16,864 | +1495.5% | 0.00% | – |
| Q1 2020 | $29,000 | -95.1% | 1,057 | -93.2% | 0.00% | – |
| Q4 2019 | $595,000 | +328.1% | 15,477 | +140.6% | 0.00% | – |
| Q3 2019 | $139,000 | – | 6,432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |